In transgenic mice expressing IL-33 or IL-18 driven by a keratin-14 promoter (IL33tg and IL-18tg), AD-like inflammation develops spontaneously with the activation of ILC2s [2,3], contributing to the development and exacerbation of type 2 immunity. The gene discussed is KRT14; the disease is Alzheimer disease.